Market Indices
Latest News
 |
Atara Biotherapeutics (ATRA) Investor Deadline Approaching: Multiple Law Firms Remind...
May 18, 2026 ATRA -4.49% |
| ||
| ||
| ||
|
Price Targets
from Evercore ISI issued a price target of $9.00 for NKTX on 2026-05-18 12:38:25.The adjusted price target was set to $9.00.At the time of the announcement, NKTX...
May 18, 2026 NKTX 1.52%
from Roth Capital issued a price target of $3.50 for NMG on 2026-05-18 12:06:42.The adjusted price target was set to $3.50.At the time of the announcement, NMG...
May 18, 2026 NMG -2.60%
Justin Clare from Roth Capital issued a price target of $2.00 for GWH on 2026-05-18 12:05:19.The adjusted price target was set to $2.00.At the time of the announcement,
May 18, 2026 GWH -5.48%
from H.C. Wainwright issued a price target of $57.00 for ETON on 2026-05-15 13:55:17.The adjusted price target was set to $57.00.At the time of the announcement, ETON...
May 15, 2026 ETON 7.37%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| ARBEW Arbe Robotics Ltd. Warran | 0.08
55.60% | ||||||||||||||||||
| SACH Sachem Capital Corp. | 1.38
33.98% | ||||||||||||||||||
| VUZI Vuzix Corporation | 3.65
21.67% | ||||||||||||||||||
| RVPH Reviva Pharmaceuticals Ho | 0.40
21.30% | ||||||||||||||||||
| KPLTW Katapult Holdings Equity | 0.00
18.19% | ||||||||||||||||||
| LVO LiveOne, Inc. | 6.22
17.80% | ||||||||||||||||||
| DWSN Dawson Geophysical Compan | 4.47
14.32% | ||||||||||||||||||
| WGSWW WGSWW | 0.00
13.33% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP -1.25%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -5.59%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK -3.49%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 2.11%